{
  "ticker": "LLY",
  "target_date": "2025-06-06",
  "actual_date": "2025-06-06",
  "collected_at": "2025-12-08T11:51:39.682180",
  "price": {
    "open": 765.67,
    "high": 769.78,
    "low": 762.4,
    "close": 767.0662231445312,
    "volume": 2069900,
    "change_1d_pct": 0.55,
    "change_7d_pct": 7.02,
    "change_30d_pct": -10.27
  },
  "technicals": {
    "rsi_14": 55.58,
    "sma_20": 737.05,
    "sma_50": 771.84,
    "macd": -6.682,
    "macd_signal": -13.726,
    "macd_histogram": 7.044,
    "bb_upper": 773.78,
    "bb_lower": 700.32,
    "price_vs_sma20_pct": 4.07,
    "price_vs_sma50_pct": -0.62,
    "volume_ratio": 0.49
  },
  "fundamentals": {
    "market_cap": 891445575680,
    "pe_ratio": 48.721703,
    "forward_pe": 43.883934,
    "price_to_book": 37.440136,
    "price_to_sales": 15.002501,
    "profit_margin": 30.99,
    "operating_margin": 48.29,
    "roe": 96.47,
    "roa": 17.6,
    "revenue_growth": 53.9,
    "earnings_growth": 480.4,
    "debt_to_equity": 178.516,
    "current_ratio": 1.546,
    "quick_ratio": 0.724,
    "dividend_yield": 59.0,
    "fifty_two_week_high": 1111.99,
    "fifty_two_week_low": 623.78,
    "fifty_day_avg": 911.5326,
    "two_hundred_day_avg": 811.9354,
    "analyst_target": 1056.7045,
    "analyst_recommendation": "buy",
    "num_analysts": 27,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -10.57,
    "pct_from_52w_low": 59.42
  },
  "macro": {
    "spy": {
      "price": 595.72,
      "change_1d_pct": 1.03,
      "change_7d_pct": 1.54
    },
    "vix": {
      "level": 16.77,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.51
    },
    "dollar_index": {
      "level": 99.19
    },
    "gold": {
      "price": 3322.7
    },
    "regime": "BULL_NORMAL"
  },
  "news": [
    {
      "headline": "Challenges pharma companies face in push into US manufacturing",
      "source": "Yahoo",
      "datetime": 1749240997,
      "summary": "Yahoo Finance senior health reporter Anjalee Khemlani explains the pharmaceutical industry's push into domestic manufacturing in the US, as a reshoring tactic to tighten up the supply chain. Planning can still take several years to be finalized and face cost barriers amid tariffs. To watch more expe",
      "url": "https://finnhub.io/api/news?id=647e80b2671926a3baa104ef7f96ea131e061c75f5c4734f3312c9e5b565dc4d"
    },
    {
      "headline": "The Next Look At Amgen's Obesity Drug Is Coming. Here's What Investors Are Watching.",
      "source": "Yahoo",
      "datetime": 1749240397,
      "summary": "Later this month, the Street will have a fresh opportunity to gauge the potential for Amgen's experimental weight-loss drug, MariTide.",
      "url": "https://finnhub.io/api/news?id=06b89f264196d37527ecb26d7446e4fc1bba0450f69d3c1d210caea8c6eab5d7"
    },
    {
      "headline": "Is Novo Nordisk's Next Generation Obesity Pipeline a Game Changer?",
      "source": "Yahoo",
      "datetime": 1749227880,
      "summary": "NVO advances obesity pipeline with CagriSema and Amycretin while expanding through major deals amid rising competition.",
      "url": "https://finnhub.io/api/news?id=89db2cf93168bf950703950f24505c2e740578cf0834eaf02d1c4a7565f65f59"
    },
    {
      "headline": "Healthcare companies are hiring. Is it time to look for growth stocks in this beaten-down sector?",
      "source": "MarketWatch",
      "datetime": 1749226080,
      "summary": "Healthcare companies are hiring. Is it time to look for growth stocks in this beaten-down sector?",
      "url": "https://finnhub.io/api/news?id=7f3fa4f06245afa0d257ec16d0811730eea82c8c2d132c3f6373abc950aedd9b"
    },
    {
      "headline": "AnaptysBio: Positive RA Data Bodes Well For Continued Rosnilimab Advancement",
      "source": "SeekingAlpha",
      "datetime": 1749224369,
      "summary": "AnaptysBio, Inc.'s rosnilimab shows promise in RA & ulcerative colitis, targeting $20B+ markets. Phase 2b results highlight its potential. Click for my ANAB update.",
      "url": "https://finnhub.io/api/news?id=e2a1528124fcb823bf81c26a72d12eaf2522f65bca901d1be86ee52af6ef1edf"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-05-27",
      "description": "xslF345X05/wk-form4_1748376794.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000156/xslF345X05/wk-form4_1748376794.xml"
    },
    {
      "form": "4",
      "date": "2025-05-20",
      "description": "xslF345X05/wk-form4_1747772733.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000154/xslF345X05/wk-form4_1747772733.xml"
    },
    {
      "form": "4",
      "date": "2025-05-20",
      "description": "xslF345X05/wk-form4_1747772668.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000152/xslF345X05/wk-form4_1747772668.xml"
    },
    {
      "form": "4",
      "date": "2025-05-20",
      "description": "xslF345X05/wk-form4_1747772589.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000150/xslF345X05/wk-form4_1747772589.xml"
    },
    {
      "form": "4",
      "date": "2025-05-20",
      "description": "xslF345X05/wk-form4_1747772518.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000148/xslF345X05/wk-form4_1747772518.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}